Jason Rudolph, MD
Foot and Ankle Surgery · Bethlehem, PANPI 1023052446
Payments from drug & device makers
Across 87 payments — averaging $170.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$8K
- Novus Surgical Consultants$3K
- Stryker$1K
- Novus Surgical Solutions LLC$1K
- Johnson & Johnson$182
- Globus Medical$133
- plus $502 from 12 others
What the payments were for
- Speaking & faculty fees$5,00034%
- Travel & lodging$5,50237%
- Food & beverage$3,12321%
- Education$1,2008%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 34 | $8,430 |
| Novus Surgical Consultants | 19 | $3,011 |
| Stryker | 8 | $1,337 |
| Novus Surgical Solutions LLC | 2 | $1,230 |
| Johnson & Johnson(2 entities) | 4 | $182 |
| Globus Medical | 1 | $133 |
| Electronic Waveform Lab, Inc. | 5 | $94 |
| Zimmer Biomet | 1 | $94 |
| Acumed LLC | 1 | $74 |
| Acera Surgical, Inc. | 2 | $45 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| ERMI LLC | 2 | $34 |
| AbbVie | 1 | $33 |
| Treace Medical Concepts, Inc. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $20 |
| Solventum Corporation | 1 | $20 |
| Bioventus LLC | 1 | $18 |
| Polymedics Innovations Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY ADAPTIS$904
- AUGMENT INJECTABLE$272
- VALOR$143
- ORTHOLOC 2 LAPIFUSE$143
- PROPHECY$143
- Tibial Nail$133
- INSTRUMENTS$108
How this compares
$14,824 in reported general payments places this provider in the 85th percentile of 575 foot and ankle surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 67 | $373 |
| Methylprednisolone | 21 | $165 |
| Naproxen | 14 | $101 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Bethlehem
- Stephen BrigidoBethlehem$656K
- Brent BernsteinBethlehem$44K
- William DecarboBelle Vernon$3.5M
- David PedowitzBryn Mawr$1.7M
- Noman SiddiquiScranton$1.3M
- Peter MangonePittsburgh$1.1M
- Guido LaportaDunmore$625K
- Jason MillerMalvern$551K
- Adam TeichmanAllentown$545K
- Thomas RocchioAllentown$524K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.